The global psychedelics market is growing rapidly, and is expected to reach $8 billion by 2029. The market currently consists primarily of pharmaceuticals, but demand—along with a supporting body of science—is growing for natural psychedelics. To provide an update on where the market stands, as well as opportunities and potential...
Silver Spring, MD—The American Herbal Products Association (AHPA) is gearing up to host its Regulatory Congress. The event, taking place virtually on November 15, will deliver the latest updates and guidance on matters affecting the regulatory landscape of the dietary supplement and natural products industries. A few of the sessions by...
Silver Spring, MD—At the board meeting on March 8, 2022, the American Herbal Products Association (AHPA) Board of Trustees chartered the AHPA Psychedelic Plants and Fungi Committee, according to a press release. The purpose of the committee will be to address issues related to the safe use and responsible commerce...
Vista, CA—Dr. Bronner’s has expanded its mental healthcare benefits to include Ketamine Assisted Therapy, according to a press release, as a first step in providing access to Psychedelic Assisted Therapy to employees to promote mental health. The benefit plan is administered by Enthea, a non-profit healthcare organization responsible for medical...
Digital Edition Editorial: Immune Market in 2022: What you need to know now What’s Selling Tip of the Month: Using Caution with Claims Adaptogens: Helping Us Deal with the 2020s 2022 Heart Health Update Grocery Feature: Raise a Glass to Healthy Energy! Supplement Highlights: Male Performance Boosters Herb of...
Psychedelics are moving into the spotlight through decriminalization bills in Oregon and California—but there’s still a gap in understanding and in acceptance. Naturally Informed did its part to address this issue via education at the Mental Wellness: Mastering the Market event in 2021. David Bronner, Cosmic Engagement Officer (CEO) of...
London and New York—Two thirds (66%) of doctors in a recent survey say they believe psilocybin therapy has potential therapeutic benefit for patients with treatment-resistant depression (TRD). That's according to a survey sponsored by Compass Pathways plc, a mental health care company dedicated to accelerating patient access to evidence-based innovation...
Guelph, Ontario, CA—Nutrasource Pharmaceutical and Nutraceutical Services has announced the approval of an amendment to its Controlled Drugs & Substances Dealer’s License issued by Health Canada earlier this year. The license was expanded to include several controlled psychedelic, psychostimulant, and pain management drugs, including: Psilocybin Psilocin Ketamine LSD Methamphetamines Synthetic...
Virtual—On January 20-21, 2020, WholeFoods Magazine and Trust Transparency Center will host our next virtual event in the #NaturallyInformed series: Mental Wellness: Mastering the Market. This event will cover a range of pressing topics focused on boosting brainpower with strategies such as nootropics and brain hacking, as well as fostering mental wellbeing by...
Columbus, OH—Black, Indigenous, and people of color (BIPOC) whose encounters with racism have had lasting harm may benefit from a single positive experience on a psychedelic drug, according to a new study from Ohio State University. The researchers recruited participants in the United States and Canada, assembling a sample of...
